ΚΑΛΥΤΕΡΗ ΖΩΗ

Tags:

New research released from the Society to the Study of Addiction produced positive news about two medications used to aid the prevention of lapse in alcoholics in treatment attempting to stay sober. The drugs, acamprosate (marketing name: Campral) and naltrexone (ReVia) were found to help you those struggling in several phases of recovery. Acamprosate helped manage emotional triggers in those who had already stopped drinking, naltrexone helped manage cravings in heavy drinkers who are looking to stop drinking or recently quit.

Using two separate drugs to lose weight can be very effective there are combinations in front of the FDA now awaiting approval. When dealing with weight loss and the people who go through it you need to err on the side of caution and allow FDA do its job and demand some research be done so the public is aware of the side effects and dangers of the medications before we drive them. Keep in mind that drug companies come in business to earn money and that they would say everything to keep people on their medications.

Researchers found out that participants taking this drug for the year, dropped excess weight within a month and have kept the extra weight off through the entire 56 weeks of the study. Contrave is a combination from the drugs naltrexone and bupropion, which usually reflect a fresh trend of weight-loss drugs that are made up of multiple active ingredient, which might make them far better and safer.

Combo-pilling may be the newest fad or even better the newest in the future under scrutiny and for that reason it is just more publicly known although in the past, comb-pilling for weight reduction has been around since the eighties. The biggest reason that utilizing a combination of pills has become popular could be the fact that since right now there are no long term prescription slimming capsules that have been authorized by the FDA aside from orlistat. The truly disturbing part is doctors are prescribing these combinations of medications and some of the combinations have been rejected or have yet to be authorized by the FDA.

Seizures certainly are a side effect with Contrave and shouldn't be taken in people with seizure disorders. The drug could also raise blood pressure levels and heartbeat, and must not be used in those with a history of heart attack or stroke in the previous six months. Blood pressure and pulse should also be measured before beginning the drug and throughout therapy with the drug.

The FDA also warned that Contrave can raise blood pressure and heartrate and must stop used in patients with uncontrolled high blood pressure level, as well as by a person with heart-related and cerebrovascular (circulation dysfunction impacting your brain) disease. Patients having a history of heart attack or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded in the clinical trials. Those taking Contrave needs to have their heart-rate and pulse monitored regularly. In addition, considering that the compound includes bupropion, Contrave comes using a boxed warning to alert physicians and patients for the increased risk of suicidal thoughts and behaviors related to antidepressant drugs. The warning also notes that serious neuropsychiatric events have been reported in patients taking bupropion for quitting smoking.

Other people who should not use Contrave are patients struggling with bulimia, anorexia nervosa, anyone using opiods, and patients undergoing an 'abrupt discontinuation of alcohol, benzodiazepines, barbiturates and antiepileptic drugs.' Lastly Concave should not be prescribed for ladies who are pregnant or wanting to become pregnant.